Order results by:
| Issue | Title | |
| Vol 5, No 1 (2013) | Dopamine dysregulation syndrome in Parkinson’s disease | Abstract similar documents |
| A V Nikitina, Natalia Vladimirovna Fedorova | ||
| "... or hypersexuality, the dose of dopaminergic receptor agonists was gradually reduced and subsequently discontinued. ..." | ||
| Vol 6, No 1 (2014) | Apathy in Parkinson's disease patients | Abstract similar documents |
| M. R. Nodel | ||
| "... pathy in Parkinson's disease (PD) patients is one of the least studied manifestations of a broad ..." | ||
| Vol 15, No 6 (2023) | Effect of dopaminergic therapy on lacrimation in Parkinson's disease | Abstract similar documents |
| A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov, A. V. Kuchuk | ||
| "... The prevalence of dry eye syndrome (DES) in Parkinson's disease (PD) reaches 87% and leads ..." | ||
| Vol 17, No 3 (2025) | Parkinson's disease and migraine | Abstract similar documents |
| Z. A. Zalyalova, E. A. Katunina, D. V. Pokhabov | ||
| "... Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Migraine ..." | ||
| Vol 4, No 1 (2012) | Sustained-release pramipexole in the treatment of Parkinson’s disease | Abstract similar documents |
| Natalia Vladimirovna Fedorova | ||
| "... for dopaminergic deficiency in Parkinson’s disease (PD). Since 1996, pramipexole has been used to treat early ..." | ||
| Vol 1, No 2 (2009) | RESTLESS LEGS SYNDROME | Abstract similar documents |
| D. V. Artem'ev | ||
| Vol 12, No 5 (2020) | On the heterogeneity of depression in Parkinson’s disease | Abstract similar documents |
| M. R. Nodel, N. N. Yakhno | ||
| "... Depression in Parkinson’s disease (PD) is one of the leading manifestations of the disease, which ..." | ||
| Vol 6, No 4 (2014) | Dopaminergic deficiency syndrome in the picture of severe brain injury in the presence of protracted depression of consciousness | Abstract similar documents |
| M. V. Chelyapina, E. V. Sharova, O. S. Zaitsev | ||
| "... Objective: to determine the clinical and electroencephalographic (EEG) signs of dopaminergic ..." | ||
| Vol 3, No 1 (2011) | Sleep disorders in Parkinson's disease | Abstract similar documents |
| M. R. Nodel | ||
| "... of Parkinson's disease (PD). Objective: to specify the clinical features of sleep disorders in patients ..." | ||
| Vol 8, No 4 (2016) | HYPERSOMNIA AND CIRCADIAN DISTURBANCES IN PARKINSON’S DISEASE | Abstract similar documents |
| M. R. Nodel | ||
| "... studied symptoms of Parkinson’s disease (PD). It manifests as constant excessive sleepiness during the day ..." | ||
| Vol 6, No 3 (2014) | Current therapy for Parkinson's disease | Abstract similar documents |
| A. V. Obukhova | ||
| "... The main goal of therapy for Parkinson's disease (PD) is to correct dopamine deficiency ..." | ||
| Vol 4, No 2 (2012) | Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease | Abstract similar documents |
| S N Illarioshkin | ||
| "... Dopaminergic stimulation with levodopa, a biological precursor of dopamine precursor, and dopamine ..." | ||
| Vol 6, No 4 (2014) | Nondrug therapy in the combination rehabilitation of patients with Parkinson’s disease | Abstract similar documents |
| V. L. Golubev, A. B. Kamakinova | ||
| "... Non-drug rehabilitation in Parkinson’s disease (PD) has recently attracted the increasing ..." | ||
| Vol 11, No 3 (2019) | The use of vortioxetine for the correction of depression in Parkinson's disease: an example of clinical cases | Abstract similar documents |
| I. V. Miliukhina | ||
| "... The prevalence of depression in Parkinson's disease (PD) amounts to as much as 90%. The paper ..." | ||
| Vol 16, No 6 (2024) | Comorbidity of sialorrhea and depression in patients with Parkinson's disease, their mutual influence on the severity of symptoms and the success of therapy | Abstract similar documents |
| D. V. Zakharov, D. D. Kokareva | ||
| "... of Parkinson's disease at all stages of the disease. They impair the patient's quality of life and ability ..." | ||
| Vol 15, No 1 (2023) | The gut microbiome as a factor in the development of Parkinson's disease | Abstract similar documents |
| L. A. Brsikyan, E. A. Poluektova, M. G. Poluektov | ||
| "... Parkinson's disease (PD) is a neurodegenerative disease characterized by the progressive death ..." | ||
| Vol 3, No 3 (2011) | Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect®) | Abstract similar documents |
| M. R. Nodel | ||
| "... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a broad spectrum ..." | ||
| Vol 13, No 5 (2021) | Biological basis of aggressive behavior | Abstract similar documents |
| O. A. Makushkina, O. I. Gurina, V. A. Golenkova | ||
| "... The review analyzes the role of serotonergic, dopaminergic, noradrenergic, and glutamatergic ..." | ||
| Vol 14, No 2 (2022) | Association between redox imbalance, pterin metabolism markers, and early extrapyramidal side effects of antipsychotics in schizophrenia: pilot study | Abstract similar documents |
| T. V. Zhilyaeva, D. S. Shvachkina, A. S. Piatoikina, E. S. Zhukova, O. V. Kostina, T. G. Shcherbatyuk, G. E. Mazo | ||
| "... effects (SE), in particular, with extrapyramidal (EP). Data suggests that oxidative damage to dopaminergic ..." | ||
| Vol 14, No 1 (2022) | Biological basis of aggressive behavior | Abstract similar documents |
| O. A. Makushkina, O. I. Gurina, V. A. Golenkova | ||
| "... , dopaminergic, noradrenergic, glutamatergic systems, and neuroendocrine mechanisms in aggression manifestation ..." | ||
| Vol 5, No 2 (2013) | Emergence from protracted unconsciousness due to severe diffuse axonal brain injury: clinical observation and literature review | Abstract similar documents |
| Evgenia Vladimirovna Aleksandrova, O S Zaitsev, M V Chelyapina, E V Sharova, E Yu Sokolova, V M Gavrilov, N E Zakharova, Yu V Vorobyev, V D Tenediyeva, V A Shurkhai, E M Troshina, A A Potapov | ||
| "... for the efficiency of use of not only direct stimulants of dopaminergic transmission, but also drugs with indirect ..." | ||
| Vol 15, No 3 (2023) | Parkinson’s disease. Focus on early stages | Abstract similar documents |
| E. A. Katunina, Z. A. Zalyalova, D. V. Pokhabov, M. Z. Ivanova, A. M. Semenova | ||
| "... in the early stages of Parkinson’s disease (PD) and considers the hypothesis of the presence of body-first ..." | ||
| Vol 6, No 4 (2014) | The epidemiological, clinical, and genetic characteristics of Parkinson’s disease (in case of Zheleznogorsk) | Abstract similar documents |
| M. R. Sapronova, N. A. Shnaider | ||
| "... Parkinson’s disease (PD) is the second most common human neurodegenerative disorder. Genetically ..." | ||
| Vol 5, No 2 (2013) | Current possibilities of therapy for sleep disorders in Parkinson’s disease | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... and awakening disorders in patients with Parkinson's disease (PD). It covers the current views of the role ..." | ||
| Vol 16, No 3 (2024) | Treatment of the early stages of Parkinson's disease. Differences in approaches to the choice of therapy in different countries | Abstract similar documents |
| E. V. Bril, N. V. Fedorova, T. K. Kulua, O. S. Zimnyakova | ||
| "... The review addresses an approach to the treatment of early stages of Parkinson's disease (PD ..." | ||
| Vol 9, No 4 (2017) | Neuropsychological pattern of Parkinson's disease | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova, M. R. Sapronova | ||
| "... The review deals with the problem of neuropsychological disorders in Parkinson's disease (PD), one ..." | ||
| Vol 9, No 1 (2017) | The genetic basis of Parkinson's disease | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, P. I. Gurieva, N. A. Shnaider, M. M. Petrova, M. R. Sapronova | ||
| "... Parkinson's disease (PD) is a multifactorial disease that develops in the presence of both genetic ..." | ||
| Vol 2, No 4 (2010) | Depression in Parkinson's disease | Abstract similar documents |
| M. R. Nodel' | ||
| "... Parkinson's disease (PD) is a multisystemic neurodegenerative disease with a wide spectrum ..." | ||
| Online-first | Features of pathogenesis and clinical manifestation of Parkinson's disease developed from essential tremor | Abstract similar documents |
| A. V. Kudrevatykh, I. V. Miliukhina | ||
| "... In last decades, there is evidence of the relationship of Parkinson's disease (PD) and essential ..." | ||
| Vol 11, No 2 (2019) | Pathogenesis, clinical features, and treatments of depression in Parkinson's disease | Abstract similar documents |
| I. V. Milyukhina | ||
| "... Depression is the most common non-motor manifestation of Parkinson's disease (PD), which ..." | ||
| Vol 3, No 4 (2011) | Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole | Abstract similar documents |
| M. R. Nodel | ||
| "... Fatigability is a common nonmotor symptom in Parkinson's disease (PD), which worsens quality ..." | ||
| Vol 9, No 4 (2017) | Sleep disorders in Parkinson’s disease: approaches to treatment and prevention | Abstract similar documents |
| M. R. Nodel, G. V. Kovrov | ||
| "... Nocturnal sleep disorders are one of the most important non-motor manifestations of Parkinson’s ..." | ||
| Vol 4, No 1 (2012) | Sleep and awakening disorders in Parkinson’s disease: comprehensive approach to therapy | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... and awakening disorders in patients with Parkinson’s disease (PD). It covers the current views of the role ..." | ||
| Vol 15, No 3 (2023) | Vitamin B12 deficiency and Parkinson’s disease | Abstract similar documents |
| Z. A. Zalyalova, E. V. Ekusheva | ||
| "... Parkinson’s disease (PD) is a progressive neurodegenerative disease with various clinical ..." | ||
| Vol 17, No 3 (2025) | Autonomic cardiovascular dysregulation and other non-motor manifestations of Parkinson’s disease | Abstract similar documents |
| A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov | ||
| "... Most patients with Parkinson’s disease (PD) experience autonomic cardiovascular dysfunction ..." | ||
| Vol 2, No 3 (2010) | Treatment of parkinson's disease at a young age | Abstract similar documents |
| D. V. Artemyev | ||
| "... and middle-aged patients. It is stressed that early-onset Parkinson's disease (PD) shows a number ..." | ||
| Vol 1, No 2 (2009) | NERVOUS AND MENTAL DISORDERS OF PARKINSON'S DISEASE | Abstract similar documents |
| M. R. Nodel', N. N. Yakhno | ||
| "... Parkinson's disease (PD) is a multisystemic neurodegenerative disease involving different mediator ..." | ||
| Vol 16, No 5 (2024) | Gidazepam – daytime tranquilizer for the treatment of anxiety | Abstract similar documents |
| Yu. E. Azimova, D. S. Petelin | ||
| "... (TSPO), influence on the activity of the serotonergic, dopaminergic and noradrenergic systems ..." | ||
| Vol 14, No 1 (2022) | Effect of vitamin D and other indicators of phosphorus-calcium metabolism on cognitive functions and quality of life in patients with Parkinson's disease | Abstract similar documents |
| D. A. Novotnyy, N. G. Zhukova, L. P. Shperling, V. A. Stolyarova, I. A. Zhukova, A. E. Agasheva, S. V. Shtaimets, O. A. Druzhinina, I. V. Shirokikh | ||
| "... Parkinson’s disease (PD) is a multifactorial neurodegenerative disease. Consequently, there has ..." | ||
| Vol 5, No 2 (2013) | Neuropsychological syndromes in patients with Parkinson’s disease after deep electric stimulation of pallidar complex structures | Abstract similar documents |
| Yu V Mikadze, Irina Igorevna Titkova, A O Gushcha, V M Tyurnikov | ||
| "... The paper provides the results of neuropsychological examinations in 10 patients with Parkinson’s ..." | ||
| Vol 4, No 3 (2012) | Clinical experience with requip modutab | Abstract similar documents |
| Denis Valeryevich Zakharov, V A Mikhailov | ||
| "... of therapy for extensive-stage Parkinson’s disease (PD) and to correct motor fluctuations and drug-induced ..." | ||
| Vol 5, No 2 (2013) | The clinical picture of early-stage Parkinson’s disease. errors in the diagnosis of different forms | Abstract similar documents |
| E N Gubanova, Natalia Vladimirovna Fedorova | ||
| "... The paper describes the clinical picture of Parkinson’s disease (PD), by indicating its stages ..." | ||
| Vol 5, No 1 (2013) | Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease | Abstract similar documents |
| Oleg Semenovich Levin, V K Datiyeva | ||
| "... receptor agonist (DRAs), which has been widely used to treat Parkinson’s disease (PD) in foreign countries ..." | ||
| Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
| I. V. Miliukhina | ||
| "... Depression is one of the most common non-motor manifestations of Parkinson's disease (PD), which ..." | ||
| Vol 9, No 1 (2017) | The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease | Abstract similar documents |
| G. N. Akhmadeeva, R. V. Magzhanov, G. N. Tayupova, A. R. Baitimerov | ||
| "... with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features ..." | ||
| Vol 13, No 3 (2021) | Sleep disorders in acute and chronic pain | Abstract similar documents |
| M. G. Poluektov, A. O. Golovatyuk | ||
| "... sleep duration occurs due to opioid, serotonergic, noradrenergic, and dopaminergic antinociceptive ..." | ||
| Vol 14, No 4 (2022) | Piribedil in the treatment of mental and cognitive impairments in Parkinson's disease | Abstract similar documents |
| E. V. Yakovenko, F. A. Abbasov | ||
| "... Mental and cognitive impairments are common non-motor symptoms of Parkinson's disease (PD), which ..." | ||
| Vol 12, No 1 (2020) | Pharmacogenetics of drug-induced dyskinesias in Parkinson's disease | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, T. G. Govorova, N. A. Shnaider, M. R. Sapronova | ||
| "... Levodopa remains the gold standard of treating Parkinson's disease (PD). However, the inevitable ..." | ||
| Vol 5, No 3 (2013) | The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... patch in Parkinson's disease (PD) and discusses the results of clinical trials of Rotigotine in early ..." | ||
| Vol 16, No 3 (2024) | Clinical and neurophysiological features of the augmentation phenomenon in restless legs syndrome | Abstract similar documents |
| N. A. Gorbachev, A. V. Obukhova, L. A. Fedeneva, M. G. Poluektov | ||
| "... treatment method for RLS is the use of dopaminergic medications. In some cases, the use of these drugs leads ..." | ||
| Vol 13, No 6 (2021) | Possibilities of using amantadines in the setting of the novel coronavirus infection in patients with Parkinson's disease | Abstract similar documents |
| E. A. Katunina, Yu. N. Bezdolnyi, N. N. Shipilova | ||
| "... . Patients and methods. The study included 75 patients with Parkinson's disease (PD): 49 (65.3%) women and 26 ..." | ||
| Vol 7, No 3 (2015) | Experience in using levodopa-benserazide | Abstract similar documents |
| Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova | ||
| "... Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper ..." | ||
| Vol 9, No 3 (2017) | Screening for non-motor symptoms in Parkinson's disease using the NMSQuest scale | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova | ||
| "... The clinical picture of Parkinson's disease (PD) includes a wide range of non-motor symptoms (NMS ..." | ||
| Vol 16, No 2 (2024) | Efficacy of antiparkinsonian therapy in tremor correction according to tremorography | Abstract similar documents |
| V. A. Bogacheva, D. V. Zakharov, V. A. Mikhailov | ||
| "... the frequency-amplitude characteristics in the correction of tremulous hyperkinesis in Parkinson's disease (PD ..." | ||
| Vol 14, No 6 (2022) | A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study | Abstract similar documents |
| Z. A. Zalyalova, S. E. Munasipova, D. M. Khasanova, G. R. Ilyina, Z. G. Khayatova, N. I. Bagdanova | ||
| "... effects. There is anecdotal evidence that patients with Parkinson's disease (PD) treated with amantadine ..." | ||
| Vol 12, No 6 (2020) | Cerebral glucose metabolism and cognitive impairment in tremor-dominant and akinetic-rigid subtypes of Parkinson’s disease | Abstract similar documents |
| I. V. Miliukhina, Yu. G. Khomenko, E. V. Gracheva, G. V. Kataeva, E. A. Gromova | ||
| "... Parkinson’s disease (PD) is a disease characterized by marked phenotypic heterogeneity ..." | ||
| Vol 11, No 3 (2019) | The features of the pathogenesis and clinical picture of Parkinson's disease that has developed in essential tremor | Abstract similar documents |
| A. V. Kudrevatykh, I. V. Miliukhina | ||
| "... In the past decades, there has been evidence on the relationship between Parkinson's disease (PD ..." | ||
| Vol 7, No 4 (2015) | Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use | Abstract similar documents |
| N. V. Trofimova, I. S. Preobrazhenskaya | ||
| Vol 4, No 1 (2012) | Association of the dopamine receptor (DRD4, DAT) gene polymorphisms with vital exhaustion in an open population among 25—64-year-old men (Novosibirsk): Epidemiological study according to the WHO MONICA-psychosocial program | Abstract similar documents |
| Valery Vasilyevich Gafarov, M I Voyevoda, E A Gromova, V N Maksimov, A V Gafarova, I V Gagulin, N S Yudin, T M Mishakova | ||
| "... Ассоциация полиморфизма генов дофаминергической системы (DRD4, DAT) с жизненным истощением в ..." | ||
| Vol 13, No 1 (2021) | Nociception: the roles of vitamin D | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, M. V. Putilina, I. S. Sardaryan, L. E. Fedotova, O. A. Limanova | ||
| "... -inflammatory action and the regulation of serotonergic, dopaminergic, and opioidergic neurotransmission ..." | ||
| Vol 10, No 4 (2018) | Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease | Abstract similar documents |
| M. R. Nodel, K. V. Shevtsova, G. V. Kovrov, N. N. Yakhno | ||
| "... Daytime sleepiness is one of the clinically significant non-motor manifestations of Parkinson ..." | ||
| Vol 10, No 4 (2018) | Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease | Abstract similar documents |
| Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova | ||
| "... Motor and non-motor symptoms are identified in the clinical picture of Parkinson's disease (PD ..." | ||
| Vol 3, No 1 (2011) | Heart rhythm variability analysis in patients with Levy body dementia and in those with Parkinson's disease | Abstract similar documents |
| I. G. Tishkova, I. S. Preobrazhenskaya | ||
| "... ) and Parkinson's disease (PD). Objective: to analyze autonomic provision of cardiac performance in patients ..." | ||
| Vol 10, No 4 (2018) | Chemoreactome analysis of tolperisone, tizanidine, and baclofen molecules: anticholinergic, antispasmodic, and analgesic mechanisms of action | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, V. A. Semenov | ||
| "... , dopaminergic, GABAergic neurotransmission. Each of the studied molecules was established to exert dose ..." | ||
| Vol 12, No 4 (2020) | Chemotranscriptome analysis indicates the neurotrophic and neuromodulator effects of a citicoline molecule | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, V. A. Semenov, I. A. Shchukin | ||
| "... , including antiepileptic drugs (n=20), dopaminergic agents (n=19), antipsychotics (n=38), anxiolytics (n=21 ..." | ||
| Vol 11, No 2 (2019) | Susceptibility-weighted MR imaging (SWI) of basal ganglia iron deposition in the early and advanced stages of Parkinson's disease | Abstract similar documents |
| A. G. Trufanov, A. A. Yurin, A. B. Buriak, S. A. Sandalov, M. M. Odinak, I. V. Litvinenko | ||
| "... Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer ..." | ||
| Vol 10, No 2 (2018) | Parkinson's disease and polymorphisms of the glutamatergic system genes GRIN2A, SLC1A2, and GRIK4 | Abstract similar documents |
| Yu. S. Mironova, I. A. Zhukova, N. G. Zhukova, S. A. Ivanova, V. M. Alifirova, A. S. Boiko, D. Z. Osmanova, O. P. Izhboldina, A. V. Latypova | ||
| "... Parkinson's disease (PD) is now increasingly considered as a multi-system disorder associated ..." | ||
| Vol 3, No 4 (2011) | Individual functional interhemispheric asymmetry profile and clinical and neurophysiological features in patients with Parkinson's disease | Abstract similar documents |
| M. A. Bykanova, A. Yu. Kovalchuk, N. V. Pizova, N. G. Efremenko, A. A. Kostylev | ||
| "... ) in 70 patients (28 men and 42 women) with Parkinson's disease (PD), by using the examination protocol ..." | ||
| Vol 16, No 3 (2024) | Psychotic disorders in Parkinson's disease: phenomenology, pathogenesis, therapeutic approaches (modern view on the problem) | Abstract similar documents |
| Kh. I. Alizade, A. A. Ragimova, E. Yu. Fedotova, S. N. Illarioshkin | ||
| "... Psychotic disorders in Parkinson's disease (PD) are common non-motor manifestations that have ..." | ||
| 1 - 70 of 81 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
